Approaches to improved antibody- and peptide-mediated targeting for imaging and therapy of cancer
Authors:
- Alan R. FritzbergAFAlan R. Fritzberg
- Paul L. BeaumierPBPaul L. Beaumier
- Becky J. BottinoBBBecky J. Bottino
- John M. RenoJRJohn M. Reno
- 1 January 1994
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 28 (1-3) , 167-173
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancerBioconjugate Chemistry, 1993
- 111In-octreotide scintigraphy in oncologyMetabolism, 1992
- The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanomaBritish Journal of Radiology, 1992
- Imaging and therapy with monoclonal antibodies in non-hematopoietic tumorsCurrent Opinion in Immunology, 1991
- Generation of bispecific monoclonal antibodies for two phase radioimmunotherapyBritish Journal of Cancer, 1991
- Review Radiolabelled monoclonal antibodies in oncology III. RadioimmunotherapyNuclear Medicine Communications, 1991
- Lymphoscintigraphy with 13I-labelled epidermal growth factorThe Lancet, 1991
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- In vivo labelling of biotinylated monoclonal antibodies by radioactive avidin: A strategy to increase tumor radiolocalizationInternational Journal of Cancer, 1988
- The structural and molecular basis of glomerular filtration.Circulation Research, 1978